Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Marinus, van Hulst"'
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 655-673 (2024)
Introduction The global measles incidence has decreased from 145 to 49 cases per 1 million population from 2000 to 2018, but evaluating the economic benefits of a second measles-containing vaccine (MCV2) is crucial. This study reviewed the evidence a
Externí odkaz:
https://doaj.org/article/f4dde6663d364afeb9ed639b92d868b9
Autor:
Darko Mitrovic, Margriet van Elp, Loes Visser, Nienke van Rein, Patricia van den Bemt, Marinus van Hulst, Albert Dreijer, Heleen Lameijer, Nic Veeger, Karina Meijer, Eric van Roon
Publikováno v:
Current Medical Research and Opinion. :1-7
Autor:
Marinus van Hulst, Jos JAM van Raay, Nic JGM Veeger, Lucia van der Veen, Marijn Segers, Carina LE Gerritsma-Bleeker, Reinoud W Brouwer
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Objectives For the non-vitamin-K oral anticoagulants, data on bleeding when used for 42 days as thromboprophylaxis after total knee arthroplasty (TKA) are scarce. This pilot study assessed feasibility of a multicentre randomised clinical trial to eva
Externí odkaz:
https://doaj.org/article/f6361e434d95442fab6054e5cd1ef0f2
Publikováno v:
BMJ Open, Vol 10, Iss 11 (2020)
Objectives In the ‘Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism’ (SELECT-D) trial, rivaroxaban showed relatively low venous thromboembolism (VTE) recurrence but hi
Externí odkaz:
https://doaj.org/article/edfb428896fd46a093fbc6d67ecf3f7e
Autor:
Marinus van Hulst, Maarten J Postma, Maartje S Jacobs, Bert Loef, Auke C Reidinga, Robert G Tieleman
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
ObjectiveCritically ill patients admitted to the intensive care unit (ICU) often develop atrial fibrillation (AF), with an incidence of around 5%. Stroke prevention in AF is well described in clinical guidelines. The extent to which stroke prevention
Externí odkaz:
https://doaj.org/article/9b5c96bd5faf41a3ad3eb505e99af13f
Autor:
Lisa A de Jong, Jessie Groeneveld, Jelena Stevanovic, Harrie Rila, Robert G Tieleman, Menno V Huisman, Maarten J Postma, Marinus van Hulst
Publikováno v:
PLoS ONE, Vol 14, Iss 9, p e0222658 (2019)
IntroductionRandomized clinical trials (RCTs) and real-world data (RWD) in patients with atrial fibrillation have shown that-compared to vitamin K antagonists (VKAs)-non-VKA oral anticoagulants (NOACs) are at least as effective in the prevention of i
Externí odkaz:
https://doaj.org/article/fcd6a7083c5348e8adbc791dc683e0ba
Publikováno v:
Vaccines, Vol 8, Iss 3, p 505 (2020)
In Ethiopia, full vaccination coverage among children aged 12–23 months has improved in recent decades. This study aimed to investigate drivers of the improvement in the vaccination coverage. The Oaxaca–Blinder decomposition technique was applied
Externí odkaz:
https://doaj.org/article/bbfe0e004ac240358dcb5780cb748d22
Autor:
Blessing Dzingirai, Maarten J. Postma, Nyashadzaishe Mafirakureva, Leolin Katsidzira, Celia Moffat Joel Matyanga, Marinus van Hulst
Publikováno v:
Journal of Viral Hepatitis
Very few low‐income countries have developed national plans to achieve the viral hepatitis elimination targets set in the World Health Organization (WHO) strategy. We reviewed the policy environment, strategies and challenges on the fight against v
Autor:
Blessing Dzingirai, Celia Matyanga, Pinky Manyau, Maarten Jacubos Postma, Marinus van Hulst, Nyashadzaishe Mafirakureva
Publikováno v:
International Journal of Technology Assessment in Health Care. 38:S11-S12
IntroductionWith ever increasing burden of disease and limited resources, health technology assessment (HTA) is required for efficient resources allocation and priority setting in healthcare. The objective of this study was to establish the baseline
Autor:
Marinus van Hulst, Robert G Tieleman, Lennaert A R Zwart, Marc Pomp, Maartje S Jacobs, Joan G Meeder, Clara E E van Ofwegen-Hanekamp, Monika Hollander, Paul Smits, Martin E W Hemels
Publikováno v:
European Heart Journal-Quality of Care & Clinical Outcomes, 9, 4, pp. 408-416
Aims Screening for atrial fibrillation (AF) is recommended by the European Society of Cardiology guidelines to prevent strokes. Cost-effectiveness analyses of different screening programmes for AF are difficult to compare because of varying settings